NCT03157167 2025-03-05An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS)Navidea BiopharmaceuticalsPhase 1 Completed15 enrolled 12 charts
NCT02201420 2016-09-27Evaluation of Tc 99m Tilmanocept Localization in Primary Cutaneous Kaposi's Sarcoma and Lymphatic Drainage by SPECT/CTNavidea BiopharmaceuticalsPhase 2 Completed5 enrolled 7 charts